Oncology Institute (DFPH) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Oncology Institute (DFPH) over the last 6 years, with Q3 2025 value amounting to -$27.7 million.
- Oncology Institute's Enterprise Value rose 4165.23% to -$27.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.7 million, marking a year-over-year increase of 4165.23%. This contributed to the annual value of -$49.7 million for FY2024, which is 4005.31% up from last year.
- Latest data reveals that Oncology Institute reported Enterprise Value of -$27.7 million as of Q3 2025, which was up 4165.23% from -$30.3 million recorded in Q2 2025.
- Oncology Institute's Enterprise Value's 5-year high stood at -$11.5 million during Q3 2021, with a 5-year trough of -$115.2 million in Q4 2021.
- Its 5-year average for Enterprise Value is -$56.1 million, with a median of -$49.7 million in 2024.
- As far as peak fluctuations go, Oncology Institute's Enterprise Value tumbled by 182020.67% in 2021, and later skyrocketed by 4577.17% in 2024.
- Oncology Institute's Enterprise Value (Quarter) stood at -$115.2 million in 2021, then soared by 35.92% to -$73.8 million in 2022, then dropped by 12.26% to -$82.9 million in 2023, then soared by 40.05% to -$49.7 million in 2024, then soared by 44.32% to -$27.7 million in 2025.
- Its Enterprise Value stands at -$27.7 million for Q3 2025, versus -$30.3 million for Q2 2025 and -$39.7 million for Q1 2025.